Literature DB >> 20133280

Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.

Julia M Hofstra1, Jack F M Wetzels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20133280     DOI： 10.1093/ndt/gfq017

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  22 in total

1.  Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy.

Authors:  Jan A J G van den Brand; Peter R van Dijk; Julia M Hofstra; Jack F M Wetzels
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

2.  Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.

Authors:  Sana Khan; W Kline Bolton
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 8.237

3.  Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

Review 4.  Management of Membranous Nephropathy in Western Countries.

Authors:  Talal Alfaadhel; Daniel Cattran
Journal:  Kidney Dis (Basel)       Date:  2015-09-09

Review 5.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

Review 6.  Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.

Authors:  Miaomiao Chen; Xuehan Zhang; Yi Xiong; Gaosi Xu
Journal:  Int Urol Nephrol       Date:  2022-09-25       Impact factor: 2.266

Review 7.  Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.

Authors:  Yizhi Chen; Arrigo Schieppati; Guangyan Cai; Xiangmei Chen; Javier Zamora; Giovanni A Giuliano; Norbert Braun; Annalisa Perna
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

8.  Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.

Authors:  Pierre-Antoine Michel; Karine Dahan; Pierre-Yves Ancel; Emmanuelle Plaisier; Rachid Mojaat; Sophie De Seigneux; Eric Daugas; Marie Matignon; Laurent Mesnard; Alexandre Karras; Hélène François; Agathe Pardon; Valérie Caudwell; Hanna Debiec; Pierre Ronco
Journal:  Nephron Extra       Date:  2011-12-24

9.  Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathy.

Authors:  Dong Ho Shin; Mi Jung Lee; Hyung Jung Oh; Hyang Mo Koo; Fa Mee Doh; Hyoung Rae Kim; Jae Hyun Han; Jung Tak Park; Seung Hyeok Han; Kyu Hun Choi; Tae-Hyun Yoo; Shin-Wook Kang
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

10.  Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.

Authors:  Andrew Howman; Tracey L Chapman; Maria M Langdon; Caroline Ferguson; Dwomoa Adu; John Feehally; Gillian J Gaskin; David R W Jayne; Donal O'Donoghue; Michael Boulton-Jones; Peter W Mathieson
Journal:  Lancet       Date:  2013-01-09       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.